Sign in

NCT06073106Recruiting

Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention

Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention Through Identification and Deep Phenotyping Methods in Healthy Aging and High-burden Disease Cohorts.

Source: ClinicalTrials.gov · Last updated 2 Oct 2026

Brief summary (registry, in English)

The aging population and its accompanying burden from non-communicable chronic diseases predicts an increasing impact imposed by frailty on healthcare systems. This is due to a lack of normative data for older adults and reliable risk stratification methods to develop effective approaches to the prevention of frailty. In this study, the investigators plan to form a common dataset for phenotype identification, risk stratification of frailty and its targeted treatment plans in the at-risk and mildly frail population.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
20 Sept 2023
Start date
1 Jan 2025
Primary completion date
Jan 2027
Lead sponsor
Tan Tock Seng Hospital
Diseases
Stroke
NCT number
NCT06073106

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 1 Jan 2025 to the primary completion date, Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous knee arthroplasty

Other illness

  • Impairments affecting understanding of questionnaires and tasks: e.g. severe deafness, severe visual impairment and severe /global aphasia,
  • Presence of active fractures, dislocations, non-weight bearing status, burns, unhealed wounds, active skin infections/eczema and agitated behaviour or delirium
  • Presence of tracheostomy, ventilator, renal dialysis, end-organ failure
  • Patients with disorders of consciousness.

Other

  • Nursing home or dormitory resident
  • Non-resident status in Singapore (e.g. foreign worker, tourist, temporary visit pass)
  • Anticipated life expectancy \< 1 year
  • Pregnant or lactating participants
    • For Knee Osteoarthritis patients only:
  • Alternative diagnosis to knee OA e.g. Referred pain from hip or spine.
  • Other forms of knee arthritis eg. Inflammatory, post traumatic

Who the study is looking for

  • Age ≥ 50y
  • Asian ethnicity
  • First diagnosis (stroke, Traumatic Brain Injury (TBI), knee osteoarthritis, breast cancer)
  • Living in community
  • Able to understand 1 step simple commands
  • For inpatients: (i) within 12 weeks of disease (stroke/TBI) onset, and (ii) within 2 weeks of rehabilitation ward admission
  • For outpatients: (i) \>6 months from initial diagnosis of first stroke, TBI, knee osteoarthritis or breast cancer, and (ii) at least standby assistance, modified independent or independent in ambulation with /without walking.

Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Tan Tock Seng Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.